Australia's largest stock trading and investment forum Australia's #1 stock forum

9SP

Click for more information

0.00%

2.0¢ 9 spokes international limited

So we currently have a 47c valuation based on a run rate about...

First 12 Last

Share
Profile

Follow
TwinTurboCelica

9,328 Posts.

190

21/07/17

09:54

Post #: 25998717
Share
Originally posted by antistar ↑

From New Fosters report:

Recommendation and Price Target:

• We maintain our BUY recommendation and price target at $0.47/share. Given the breadth of the business development pipeline and progress that 9SP has made on a range of large prospects over the last quarter, we are confident that the company is likely to succeed in winning at least two channel partners in the near term.

Catalysts for the share price include: 1) end-user customer adoption, 2) additional channels in existing jurisdictions; and 3) additional channels in new jurisdictions.

As last reported in early June, adoption rates by Barclay’s end-users were accelerating, with National promotional roll-out on-going. Based on run-rate, 9SP users would be c.38.5k by Jun-18 (2.5kusersaddedpermthx13mths+6ksubscriberstoday=38.5kendusers). However,wewould not be surprised to see the run-rate double, with Barclays ramping-up marketing initiatives. We believe 41k end users by Dec-17 is feasible (5k users added per mth x 7 mths + 6k subscribers today = 41k end users).

Expand

So we currently have a 47c valuation based on a run rate about 1/3 of what we are now achieving. Wonder if a new valuation will be released soon?
9SP Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 4 more messages in this thread...

First 12 Last

Add 9SP (ASX) to my watchlist